ALACHUA, Fla., Feb. 27 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc.
(Amex: TTG), a leading manufacturer of sterile biological implant products
made from human (allograft) and animal (xenograft) tissue, announced to
today that Guy Mayer, President and Chief Executive Officer, and Robert
Johnston, Chief Financial Officer, will be presenting at the Raymond James
28th Annual Institutional Investor Conference at the Hyatt Regency Grand
Cypress in Orlando, FL on Wednesday, March 7, 2007 at 10:25 a.m. ET.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products
made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes
its Tutoplast Process(R) of tissue preservation and viral inactivation to
manufacture and deliver sterile bio-implants used in spinal/trauma,
urology, dental, ophthalmology, and general surgery procedures. The
Company's Tutoplast(R) products are sold and distributed worldwide by
Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc.,
Davol Inc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor),
Coloplast Corp., IOP, Inc. and through independent distributors
internationally. For more information, visit the Company's Web site at
http://www.tutogen.com.
Forward-Looking Statement Disclaimer: This press release contains
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements typically are
identified by use of terms such as "may," "will," "should," "plan,"
"expect," "anticipate," "estimate," and similar words, although some
forward-looking statements are expressed differently. These statements
include, but are not limited to, statements made by the Company's Chief
Executive Officer concerning the Company's recent financial performance and
trends of quarterly revenue increases, progress toward profitability, the
potential for growth in sales and continued market acceptance of the
Company's hernia repair, breast reconstruction and new spine products,
potential growth in the Company's dental and international markets, and
management's excitement about the Company's future opportunities.
Forward-looking statements are based on management's current expectations
and are subject to certain risks and uncertainties that could cause actual
results to differ materially from those set forth or implied by
forward-looking statements. These and other risks are identified in the
Company's filings with the Securities and Exchange Commission, including
the Company's Annual Report on Form 10-K for the fiscal year ended
September 30, 2006. All information in this press release is as of the date
hereof, and the Company undertakes no duty to update this information
unless required by law.
Contacts:
L. Robert Johnston, Jr. Lytham Partners, LLC
Chief Financial Officer Joe Diaz
Tutogen Medical, Inc. Joe Dorame
386-462-0402 Robert Blum
bjohnston@tutogen.com 602-889-9700
SOURCE Tutogen Medical, Inc.
 back to top
Related links:
http://www.tutogen.com
CONTACT:
L. Robert Johnston, Jr., Chief Financial
Officer of Tutogen Medical, Inc., +1-386-462-0402,
bjohnston@tutogen.com; or Joe Diaz, Joe Dorame or Robert Blum,
all of Lytham Partners, LLC, +1-602-889-9700, for Tutogen
Medical, Inc.
|
